[I'm an undergrad research student at my university, doing research into Asteroseismology.] While this might be the case for medical data, I can give a counterexample of astrophysics data. As a community, we only have so many telescopes. Most of the work I'm doing is involved with the NASA Kepler space telescope, and several of my colleagues have written articles in Nature and Science about new techniques and results from data that is publicly available from that telescope. Several papers I've coauthored have mainly been new data processing techniques to learn more about stars using existing data.
So, from my perspective, the whole "research parasite" FUD was particularly ridiculous. It's incredibly arrogant to claim that you've learnt all you can learn from a single collection of data. Calling people that salvage even more information from other data sets "parasites" is incredibly arrogant.
The article criticized "rude" behavior like using someone's own data to refute their conclusion. That's the biggest bit of cluelessness in the editorial.
The solution would be to realign the incentives by giving more credit to the creators of the data.
>Krumholz: There are lot of people who feel the research they do is the best research. It comes across as self-serving and absurd. Science is about replicating and testing your work. We need scientists to test and investigate and provide new insights. … Remember, people may make errors and the only way to catch mistakes and make corrections is to see the data.To call people parasites who are taking advantage of existing data and using that to generate new knowledge is not parasitism. That’s synergy and building on work of others. … Anyone who holds that view is not seeing the big picture about how different people can work in different ways to help society advance.
There's been a lot of anger at NEJM for this editorial, largely because it used the brazenly derogatory term "research parasites," more than any other particular complaint. The same discussion happened last decade in the basic research community, as gene expression microarray studies started publishing lots of data, and no single initial publication could fully mine it. Now that the clinical science community is encountering more of this, and information dense technologies are being used to gather data during clinical trials, the same discussion is getting rehashed.
Meanwhile, those whose primary research thrust is analysis of data rather than generation often have more offers to collaborate than they could ever meet. They may not get the Science or Nature papers though, as those are typically reserved for data producers.